Skip to main content
. 2015 Jul 27;88(1054):20150185. doi: 10.1259/bjr.20150185

Figure 4.

Figure 4.

Whole-body positron emission tomography (PET)-CT imaging of 124I-cRGDY–polyethylene glycol–Cornell dots. Intravenous injection of 124I-cRGDY-PET-C-dots followed by repeat imaging in a Phase I safety and feasibility study (ClinicalTrials.gov identifier NCT01266096). Representative whole-body image of (a) CT, (b) PET at 4 h and (c) PET/CT at 4 h and (d) at 24 h. (e) Corresponding fluorine-18 fludeoxyglucose PET/CT image of hepatic metastasis in (a); (arrow). Colour and grey scales reflect PET standardized uptake value. Reproduced from Phillips et al17 with permission from American Association for the Advancement of Science.